{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T21:51:17Z","timestamp":1775944277766,"version":"3.50.1"},"reference-count":106,"publisher":"Zhejiang University Press","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"DOI":"10.1631\/jzus.b2400251","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:58:58Z","timestamp":1763704738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Roles of Wnt ligands and receptors in oral squamous cell carcinoma","Wnt\u914d\u4f53\u548c\u53d7\u4f53\u5728\u53e3\u8154\u9cde\u72b6\u7ec6\u80de\u764c\u4e2d\u7684\u4f5c\u7528"],"prefix":"10.1631","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-7216","authenticated-orcid":false,"given":"Muhammad","family":"Tufail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-0773","authenticated-orcid":false,"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"18","key":"251_CR1","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.1111\/jcmm.15667","volume":"24","author":"YL Ai","year":"2020","unstructured":"Ai YL, Wu SY, Zou C, et al., 2020. LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT\/\u03b2-catenin signaling pathway. J Cell Mol Med, 24(18):10512\u201310524. https:\/\/doi.org\/10.1111\/jcmm.15667","journal-title":"J Cell Mol Med"},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"1240159","DOI":"10.3389\/fcell.2023.1240159","volume":"11","author":"J Arebro","year":"2023","unstructured":"Arebro J, Towle R, Lee CM, et al., 2023. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer. Front Cell Dev Biol, 11:1240159. https:\/\/doi.org\/10.3389\/fcell.2023.1240159","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"251_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/cancers12030555","volume":"12","author":"YP Bai","year":"2020","unstructured":"Bai YP, Sha JJ, Kanno T, 2020. The role of carcinogenesis-related biomarkers in the Wnt pathway and their effects on epithelial\u2013mesenchymal transition (EMT) in oral squamous cell carcinoma. Cancers, 12(3):555. https:\/\/doi.org\/10.3390\/cancers12030555","journal-title":"Cancers"},{"issue":"5","key":"251_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.oraloncology.2015.01.012","volume":"51","author":"MV Bais","year":"2015","unstructured":"Bais MV, Kukuruzinska M, Trackman PC, 2015. Orthotopic non-metastatic and metastatic oral cancer mouse models. Oral Oncol, 51(5):476\u2013482. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.01.012","journal-title":"Oral Oncol"},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"113599","DOI":"10.1016\/j.biopha.2022.113599","volume":"155","author":"MLP Bueno","year":"2022","unstructured":"Bueno MLP, Saad STO, Roversi FM, 2022. WNT5A in tumor development and progression: a comprehensive review. Biomed Pharmacother, 155:113599. https:\/\/doi.org\/10.1016\/j.biopha.2022.113599","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"251_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/jbm.a.37522","volume":"111","author":"IA Cadena","year":"2023","unstructured":"Cadena IA, Buchanan MR, Harris CG, et al., 2023. Engineering high throughput screening platforms of cervical cancer. J Biomed Mater Res, 111(6):747\u2013764. https:\/\/doi.org\/10.1002\/jbm.a.37522","journal-title":"J Biomed Mater Res"},{"issue":"11","key":"251_CR7","doi-asserted-by":"publisher","first-page":"a007906","DOI":"10.1101\/cshperspect.a007906","volume":"4","author":"KM Cadigan","year":"2012","unstructured":"Cadigan KM, Waterman ML, 2012. TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol, 4(11):a007906. https:\/\/doi.org\/10.1101\/cshperspect.a007906","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"251_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1039\/D0MO00009D","volume":"16","author":"KB Chandler","year":"2020","unstructured":"Chandler KB, Alamoud KA, Stahl VL, et al., 2020. \u03b2-Catenin\/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. Mol Omics, 16(3):195\u2013209. https:\/\/doi.org\/10.1039\/d0mo00009d","journal-title":"Mol Omics"},{"issue":"10","key":"251_CR9","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41416-023-02186-1","volume":"128","author":"P Chaves","year":"2023","unstructured":"Chaves P, Garrido M, Oliver J, et al., 2023. Preclinical models in head and neck squamous cell carcinoma. Br J Cancer, 128(10):1819\u20131827. https:\/\/doi.org\/10.1038\/s41416-023-02186-1","journal-title":"Br J Cancer"},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1186\/s12885-022-09898-2","volume":"22","author":"C Chen","year":"2022","unstructured":"Chen C, Luo LN, Xu CL, et al., 2022. Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes. BMC Cancer, 22:790. https:\/\/doi.org\/10.1186\/s12885-022-09898-2","journal-title":"BMC Cancer"},{"issue":"2","key":"251_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.21873\/anticanres.16195","volume":"43","author":"P Cierpikowski","year":"2023","unstructured":"Cierpikowski P, Lis-Nawara A, Bar J, 2023. Prognostic value of WNT1, NOTCH1, PDGFR\u03b2, and CXCR4 in oral squamous cell carcinoma. Anticancer Res, 43(2):591\u2013602. https:\/\/doi.org\/10.21873\/anticanres.16195","journal-title":"Anticancer Res"},{"issue":"17","key":"251_CR12","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.3390\/cancers15174266","volume":"15","author":"E Dalir Abdolahinia","year":"2023","unstructured":"Dalir Abdolahinia E, Han XZ, 2023. The three-dimensional in vitro cell culture models in the study of oral cancer immune microenvironment. Cancers, 15(17):4266. https:\/\/doi.org\/10.3390\/cancers15174266","journal-title":"Cancers"},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"12668","DOI":"10.1038\/srep12668","volume":"5","author":"Y Dong","year":"2015","unstructured":"Dong Y, Zhao Q, Ma XY, et al., 2015. Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach. Sci Rep, 5:12668. https:\/\/doi.org\/10.1038\/srep12668","journal-title":"Sci Rep"},{"issue":"2","key":"251_CR14","doi-asserted-by":"publisher","first-page":"e8411225462","DOI":"10.33448\/rsd-v11i2.25462","volume":"11","author":"MT Farrapo","year":"2022","unstructured":"Farrapo MT, Rifane TO, Pinto DN, et al., 2022. Canonical WNT signaling pathway in oral squamous cell carcinoma prognosis. Res Soc Dev, 11(2):e8411225462. https:\/\/doi.org\/10.33448\/rsd-v11i2.25462","journal-title":"Res Soc Dev"},{"issue":"2\u20133","key":"251_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41397-022-00296-2","volume":"23","author":"A Farshbaf","year":"2023","unstructured":"Farshbaf A, Lotfi M, Zare R, et al., 2023. The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma? Pharmacogenomics J, 23(2\u20133):37\u201344. https:\/\/doi.org\/10.1038\/s41397-022-00296-2","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"251_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","volume":"23","author":"CD Fleming-de-Moraes","year":"2022","unstructured":"Fleming-de-Moraes CD, Rocha MR, Tessmann JW, et al., 2022. Crosstalk between PI3K\/Akt and Wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status. Cancer Biol Ther, 23(1):1\u201313. https:\/\/doi.org\/10.1080\/15384047.2022.2108690","journal-title":"Cancer Biol Ther"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12935-023-02853-6","volume":"23","author":"C Ge","year":"2023","unstructured":"Ge C, Huang XT, Zhang SJ, et al., 2023. In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. Cancer Cell Int, 23:14. https:\/\/doi.org\/10.1186\/s12935-023-02853-6","journal-title":"Cancer Cell Int"},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3389\/fphar.2018.01160","volume":"9","author":"M Grimaldi","year":"2018","unstructured":"Grimaldi M, Boulahtouf A, Pr\u00e9vostel C, et al., 2018. A cell model suitable for a high-throughput screening of inhibitors of the Wnt\/\u03b2-catenin pathway. Front Pharmacol, 9:1160. https:\/\/doi.org\/10.3389\/fphar.2018.01160","journal-title":"Front Pharmacol"},{"key":"251_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/CMAR.S411168","volume":"15","author":"K He","year":"2023","unstructured":"He K, Gan WJ, 2023. Wnt\/\u03b2-catenin signaling pathway in the development and progression of colorectal cancer. Cancer Manag Res, 15:435\u2013448. https:\/\/doi.org\/10.2147\/cmar.S411168","journal-title":"Cancer Manag Res"},{"issue":"2","key":"251_CR20","doi-asserted-by":"publisher","first-page":"113935","DOI":"10.1016\/j.yexcr.2024.113935","volume":"435","author":"ZY Hou","year":"2024","unstructured":"Hou ZY, Wu CZ, Tang JR, et al., 2024. CLSPN actives Wnt\/\u03b2-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma. Exp Cell Res, 435(2):113935. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113935","journal-title":"Exp Cell Res"},{"issue":"12","key":"251_CR21","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/cancers11121883","volume":"11","author":"TN Hsu","year":"2019","unstructured":"Hsu TN, Huang CM, Huang CS, et al., 2019. Targeting FAT1 inhibits carcinogenesis, induces oxidative stress and enhances cisplatin sensitivity through deregulation of LRP5\/WNT2\/GSS signaling axis in oral squamous cell carcinoma. Cancers, 11(12):1883. https:\/\/doi.org\/10.3390\/cancers11121883","journal-title":"Cancers"},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"968570","DOI":"10.3389\/fonc.2022.968570","volume":"12","author":"PC Hsueh","year":"2022","unstructured":"Hsueh PC, Chang KP, Liu HP, et al., 2022. Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma. Front Oncol, 12:968570. https:\/\/doi.org\/10.3389\/fonc.2022.968570","journal-title":"Front Oncol"},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.01.003","volume":"63","author":"F Invrea","year":"2020","unstructured":"Invrea F, Rovito R, Torchiaro E, et al., 2020. Patient-derived xenografts (PDXs) as model systems for human cancer. Curr Opin Biotechnol, 63:151\u2013156. https:\/\/doi.org\/10.1016\/j.copbio.2020.01.003","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"251_CR24","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3892\/or.2019.6974","volume":"41","author":"B Jia","year":"2019","unstructured":"Jia B, Qiu XL, Chu HX, et al., 2019. Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma. Oncol Rep, 41(3):1749\u20131758. https:\/\/doi.org\/10.3892\/or.2019.6974","journal-title":"Oncol Rep"},{"issue":"1","key":"251_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2012.10.003","volume":"24","author":"DM Joiner","year":"2013","unstructured":"Joiner DM, Ke JY, Zhong ZD, et al., 2013. LRP5 and LRP6 in development and disease. Trends Endocrinol Metab, 24(1):31\u201339. https:\/\/doi.org\/10.1016\/j.tem.2012.10.003","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"251_CR26","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3892\/ol.2017.6313","volume":"14","author":"EK Jung","year":"2017","unstructured":"Jung EK, Kim SA, Yoon TM, et al., 2017. WNT1-inducible signaling pathway protein-1 contributes to tumor progression and treatment failure in oral squamous cell carcinoma. Oncol Lett, 14(2):1719\u20131724. https:\/\/doi.org\/10.3892\/ol.2017.6313","journal-title":"Oncol Lett"},{"issue":"3","key":"251_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.7727\/wimj.2014.347","volume":"65","author":"LP Kalinke","year":"2016","unstructured":"Kalinke LP, Alvares LE, Schussel JL, et al., 2016. Expression of WNT10A gene in oral squamous cell carcinoma. West Indian Med J, 65(3):480\u2013485. https:\/\/doi.org\/10.7727\/wimj.2014.347","journal-title":"West Indian Med J"},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13073-018-0569-7","volume":"10","author":"VK Kartha","year":"2018","unstructured":"Kartha VK, Alamoud KA, Sadykov K, et al., 2018. Functional and genomic analyses reveal therapeutic potential of targeting \u03b2-catenin\/CBP activity in head and neck cancer. Genome Med, 10:54. https:\/\/doi.org\/10.1186\/s13073-018-0569-7","journal-title":"Genome Med"},{"issue":"10","key":"251_CR29","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.labinv.2023.100228","volume":"103","author":"K Kayamori","year":"2023","unstructured":"Kayamori K, Katsube KI, Hirai H, et al., 2023. Role of stromal fibroblast-induced WNT7A associated with cancer cell migration through the AKT\/CLDN1 signaling axis in oral squamous cell carcinoma. Lab Invest, 103(10):100228. https:\/\/doi.org\/10.1016\/j.labinv.2023.100228","journal-title":"Lab Invest"},{"issue":"1","key":"251_CR30","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.oooo.2019.02.086","volume":"128","author":"O Kim","year":"2019","unstructured":"Kim O, Ahn K, Kim HE, et al., 2019. Screening of \u03b2-catenin inhibitor from medicinal plant extracts for intractable recurrent oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol, 128(1):e43. https:\/\/doi.org\/10.1016\/j.oooo.2019.02.086","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"681469","DOI":"10.5402\/2012\/681469","volume":"2012","author":"S Krisanaprakornkit","year":"2012","unstructured":"Krisanaprakornkit S, Iamaroon A, 2012. Epithelial-mesenchymal transition in oral squamous cell carcinoma. Int Scholarly Res Not, 2012:681469. https:\/\/doi.org\/10.5402\/2012\/681469","journal-title":"Int Scholarly Res Not"},{"key":"251_CR32","doi-asserted-by":"publisher","first-page":"650772","DOI":"10.3389\/fcell.2021.650772","volume":"9","author":"V Kumar","year":"2021","unstructured":"Kumar V, Vashishta M, Kong L, et al., 2021. The role of notch, hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies. Front Cell Dev Biol, 9:650772. https:\/\/doi.org\/10.3389\/fcell.2021.650772","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"251_CR33","doi-asserted-by":"publisher","first-page":"e0176246","DOI":"10.1371\/journal.pone.0176246","volume":"12","author":"HK Lau","year":"2017","unstructured":"Lau HK, Wu ER, Chen MK. et al., 2017. Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility. PLoS ONE, 12(4):e0176246. https:\/\/doi.org\/10.1371\/journal.pone.0176246","journal-title":"PLoS ONE"},{"issue":"6","key":"251_CR34","first-page":"1151","volume":"20","author":"G Lee","year":"2002","unstructured":"Lee G, Kim YB, Kim JH, et al., 2002. Characterization of novel cell lines established from three human oral squamous cell carcinomas. Int J Oncol, 20(6):1151\u20131159.","journal-title":"Int J Oncol"},{"issue":"4","key":"251_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.slasd.2023.03.006","volume":"28","author":"SY Lee","year":"2023","unstructured":"Lee SY, Koo IS, Hwang HJ, et al., 2023. In vitro three-dimensional (3D) cell culture tools for spheroid and organoid models. SLAS Discov, 28(4):119\u2013137. https:\/\/doi.org\/10.1016\/j.slasd.2023.03.006","journal-title":"SLAS Discov"},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fonc.2020.00212","volume":"10","author":"Q Li","year":"2020","unstructured":"Li Q, Dong H, Yang GW, et al., 2020. Mouse tumor-bearing models as preclinical study platforms for oral squamous cell carcinoma. Front Oncol, 10:212. https:\/\/doi.org\/10.3389\/fonc.2020.00212","journal-title":"Front Oncol"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.archoralbio.2017.07.009","volume":"83","author":"BY Liu","year":"2017","unstructured":"Liu BY, Chen W, Cao G, et al., 2017. MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway. Arch Oral Biol, 83:92\u201396. https:\/\/doi.org\/10.1016\/j.archoralbio.2017.07.009","journal-title":"Arch Oral Biol"},{"issue":"1","key":"251_CR38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3892\/ol.2019.10347","volume":"18","author":"BY Liu","year":"2019","unstructured":"Liu BY, Cao G, Dong Z, et al., 2019. Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway. Oncol Lett, 18(1):667\u2013673. https:\/\/doi.org\/10.3892\/ol.2019.10347","journal-title":"Oncol Lett"},{"issue":"50","key":"251_CR39","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1073\/pnas.1314239110","volume":"110","author":"J Liu","year":"2013","unstructured":"Liu J, Pan SF, Hsieh MH, et al., 2013. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci USA, 110(50):20224\u201320229. https:\/\/doi.org\/10.1073\/pnas.1314239110","journal-title":"Proc Natl Acad Sci USA"},{"key":"251_CR40","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.2147\/OTT.S153888","volume":"11","author":"LJ Liu","year":"2018","unstructured":"Liu LJ, Jiang H, Zhao J, et al., 2018. MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt\/\u03b2-catenin signaling pathway. Onco Targets Ther, 11:5111\u20135119. https:\/\/doi.org\/10.2147\/OTT.S153888","journal-title":"Onco Targets Ther"},{"key":"251_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"YH Liu","year":"2023","unstructured":"Liu YH, Wu WT, Cai CJ, et al., 2023. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther, 8:160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"251_CR42","doi-asserted-by":"publisher","first-page":"e0174309","DOI":"10.1371\/journal.pone.0174309","volume":"12","author":"JT Ma","year":"2017","unstructured":"Ma JT, Ren YP, Zhang L, et al., 2017. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression. PLoS ONE, 12(4):e0174309. https:\/\/doi.org\/10.1371\/journal.pone.0174309","journal-title":"PLoS ONE"},{"issue":"9","key":"251_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/biomedicines9091079","volume":"9","author":"N Mehterov","year":"2021","unstructured":"Mehterov N, Vladimirov B, Sacconi A, et al., 2021. Salivary miR-30c-5p as potential biomarker for detection of oral squamous cell carcinoma. Biomedicines, 9(9):1079. https:\/\/doi.org\/10.3390\/biomedicines9091079","journal-title":"Biomedicines"},{"issue":"10","key":"251_CR44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12194","volume":"41","author":"X Meng","year":"2021","unstructured":"Meng X, Lou QY, Yang WY, et al., 2021. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. Cancer Commun (Lond), 41(10):981\u20131006. https:\/\/doi.org\/10.1002\/cac2.12194","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"251_CR45","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/j.oooo.2017.06.015","volume":"124","author":"R Menon","year":"2017","unstructured":"Menon R, Li CC, Li MZ, 2017. Wnt signaling in oral cancer initiating cells. Oral Surg Oral Med Oral Pathol Oral Radiol, 124(3):e202. https:\/\/doi.org\/10.1016\/j.oooo.2017.06.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"251_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.medj.2023.04.003","volume":"4","author":"R Millen","year":"2023","unstructured":"Millen R, de Kort WWB, Koomen M, et al., 2023. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification. Med, 4(5):290\u2013310.e12. https:\/\/doi.org\/10.1016\/j.medj.2023.04.003","journal-title":"Med"},{"key":"251_CR47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/jbt.21777","volume":"30","author":"AJ Min","year":"2016","unstructured":"Min AJ, Zhu C, Peng SP, et al., 2016. Downregulation of microRNA-148a in cancer-associated fibroblasts from oral cancer promotes cancer cell migration and invasion by targeting Wnt10b. J Biochem Mol Toxicol, 30(4):186\u2013191. https:\/\/doi.org\/10.1002\/jbt.21777","journal-title":"J Biochem Mol Toxicol"},{"key":"251_CR48","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/curroncol28040230","volume":"28","author":"C Ngernsombat","year":"2021","unstructured":"Ngernsombat C, Prattapong P, Larbcharoensub N, et al., 2021. WNT8B as an independent prognostic marker for nasopharyngeal carcinoma. Curr Oncol, 28(4):2529\u20132539. https:\/\/doi.org\/10.3390\/curroncol28040230","journal-title":"Curr Oncol"},{"issue":"2","key":"251_CR49","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.48048\/tis.2023.3892","volume":"20","author":"NT Nguyen","year":"2023","unstructured":"Nguyen NT, Doan VN, Tran HLB, 2023. Role of co-culture with fibroblasts and dynamic culture systems in 3-dimensional MCF-7 tumor model maturation. Trends Sci, 20(2):3892\u20133892. https:\/\/doi.org\/10.48048\/tis.2023.3892","journal-title":"Trends Sci"},{"key":"251_CR50","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3389\/fonc.2020.01341","volume":"10","author":"XB Nie","year":"2020","unstructured":"Nie XB, Liu HY, Liu L, et al., 2020. Emerging roles of Wnt ligands in human colorectal cancer. Front Oncol, 10:1341. https:\/\/doi.org\/10.3389\/fonc.2020.01341","journal-title":"Front Oncol"},{"issue":"3","key":"251_CR51","first-page":"873","volume":"32","author":"J Noguti","year":"2012","unstructured":"Noguti J, de Moura CFG, Hossaka TA, et al., 2012. The role of canonical WNT signaling pathway in oral carcinogenesis: a comprehensive review. Anticancer Res, 32(3):873\u2013878.","journal-title":"Anticancer Res"},{"issue":"3","key":"251_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3390\/cells9030723","volume":"9","author":"J Paluszczak","year":"2020","unstructured":"Paluszczak J, 2020. The significance of the dysregulation of canonical Wnt signaling in head and neck squamous cell carcinomas. Cells, 9(3):723. https:\/\/doi.org\/10.3390\/cells9030723","journal-title":"Cells"},{"key":"251_CR53","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3389\/fimmu.2019.02872","volume":"10","author":"S Patel","year":"2019","unstructured":"Patel S, Alam A, Pant R, et al., 2019. Wnt signaling and its significance within the tumor microenvironment: novel therapeutic insights. Front Immunol, 10:2872. https:\/\/doi.org\/10.3389\/fimmu.2019.02872","journal-title":"Front Immunol"},{"key":"251_CR54","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.99558","volume-title":"Oral Cancer\u2014Current Concepts and Future Perspectives","author":"DJ Patil","year":"2021","unstructured":"Patil DJ, Nagaraju R, 2021. Personalised precision medicine - a novel approach for oral cancer management. In: Sridharan G (Ed.), Oral Cancer\u2014Current Concepts and Future Perspectives. IntechOpen, Rijeka. https:\/\/doi.org\/10.5772\/intechopen.99558"},{"issue":"6","key":"251_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3892\/or.2023.8650","volume":"50","author":"L Pekarek","year":"2023","unstructured":"Pekarek L, Garrido-Gil MJ, S\u00e1nchez-Cendra A, et al., 2023. Emerging histological and serological biomarkers in oral squamous cell carcinoma: applications in diagnosis, prognosis evaluation and personalized therapeutics (Review). Oncol Rep, 50(6):213. https:\/\/doi.org\/10.3892\/or.2023.8650","journal-title":"Oncol Rep"},{"issue":"1","key":"251_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1158\/1078-0432.CCR-23-0318","volume":"30","author":"D Pe\u00f1a-Oyarz\u00fan","year":"2024","unstructured":"Pe\u00f1a-Oyarz\u00fan D, Flores T, Torres VA, et al., 2024. Inhibition of PORCN blocks Wnt signaling to attenuate progression of oral carcinogenesis. Clin Cancer Res, 30(1):209\u2013223. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0318","journal-title":"Clin Cancer Res"},{"issue":"suppl1","key":"251_CR57","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1016\/j.oraloncology.2013.03.307","volume":"49","author":"Z Prgomet","year":"2013","unstructured":"Prgomet Z, Lindberg P, Andersson T, 2013. PP064: Wnt5a stimulates migration and invasion in OSCC. Oral Oncol, 49(suppl 1):S115\u2013S116. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.03.307","journal-title":"Oral Oncol"},{"key":"251_CR58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/eos.12352","volume":"125","author":"Z Prgomet","year":"2017","unstructured":"Prgomet Z, Andersson T, Lindberg P, 2017. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance. Eur J Oral Sci, 125(4):237\u2013246. https:\/\/doi.org\/10.1111\/eos.12352","journal-title":"Eur J Oral Sci"},{"issue":"3","key":"251_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmgh.2020.04.007","volume":"10","author":"A Prossomariti","year":"2020","unstructured":"Prossomariti A, Piazzi G, Alquati C, et al., 2020. Are Wnt\/\u03b2-catenin and PI3K\/AKT\/mTORC1 distinct pathways in colorectal cancer? Cell Mol Gastroenterol Hepatol, 10(3):491\u2013506. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.04.007","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"8","key":"251_CR60","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.sdentj.2021.08.002","volume":"33","author":"NMS Purwaningsih","year":"2021","unstructured":"Purwaningsih NMS, Khor GH, Nik Mohd Rosdy NMM, et al., 2021. Wnt pathway in oral cancer: a review update. Saudi Dent J, 33(8):813\u2013818. https:\/\/doi.org\/10.1016\/j.sdentj.2021.08.002","journal-title":"Saudi Dent J"},{"key":"251_CR61","doi-asserted-by":"publisher","first-page":"670960","DOI":"10.3389\/fcell.2021.670960","volume":"9","author":"Q Ren","year":"2021","unstructured":"Ren Q, Chen JC, Liu YH, 2021. LRP5 and LRP6 in Wnt signaling: similarity and divergence. Front Cell Dev Biol, 9:670960. https:\/\/doi.org\/10.3389\/fcell.2021.670960","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"251_CR62","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.3390\/ijms21134682","volume":"21","author":"M Reyes","year":"2020","unstructured":"Reyes M, Flores T, Betancur D, et al., 2020. Wnt\/\u03b2-catenin signaling in oral carcinogenesis. Int J Mol Sci, 21(13):4682. https:\/\/doi.org\/10.3390\/ijms21134682","journal-title":"Int J Mol Sci"},{"key":"251_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1038\/s41598-018-33998-4","volume":"8","author":"BM Robert","year":"2018","unstructured":"Robert BM, Dakshinamoorthy M, Ganapathyagraharam Ramamoorthy B, et al., 2018. Predicting tumor sensitivity to chemotherapeutic drugs in oral squamous cell carcinoma patients. Sci Rep, 8:15545. https:\/\/doi.org\/10.1038\/s41598-018-33998-4","journal-title":"Sci Rep"},{"key":"251_CR64","doi-asserted-by":"publisher","first-page":"4536302","DOI":"10.1155\/2019\/4536302","volume":"2019","author":"Z Roslan","year":"2019","unstructured":"Roslan Z, Muhamad M, Selvaratnam L, et al., 2019. The roles of low-density lipoprotein receptor-related proteins 5, 6, and 8 in cancer: a review. J Oncol, 2019:4536302. https:\/\/doi.org\/10.1155\/2019\/4536302","journal-title":"J Oncol"},{"key":"251_CR65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.trsl.2024.03.004","volume":"268","author":"P Sa","year":"2024","unstructured":"Sa P, Singh P, Panda S, et al., 2024. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway. Transl Res, 268:63\u201378. https:\/\/doi.org\/10.1016\/j.trsl.2024.03.004","journal-title":"Transl Res"},{"issue":"5","key":"251_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/ncrna9050063","volume":"9","author":"A Sajeev","year":"2023","unstructured":"Sajeev A, BharathwajChetty B, Vishwa R, et al., 2023. Crosstalk between non-coding RNAs and Wnt\/\u03b2-catenin signaling in head and neck cancer: identification of novel biomarkers and therapeutic agents. Non-coding RNA, 9(5):63. https:\/\/doi.org\/10.3390\/ncrna9050063","journal-title":"Non-coding RNA"},{"key":"251_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.oraloncology.2017.03.019","volume":"69","author":"T Sakamoto","year":"2017","unstructured":"Sakamoto T, Kawano S, Matsubara R, et al., 2017. Critical roles of Wnt5a\u2013Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ANp63\u03b2-mediated epithelial-mesenchymal transition. Oral Oncol, 69:15\u201325. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.03.019","journal-title":"Oral Oncol"},{"issue":"2","key":"251_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41419-023-05652-z","volume":"14","author":"YH Shen","year":"2023","unstructured":"Shen YH, Chen YL, Lin YT, et al., 2023. CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma. Cell Death Dis, 14(2):107. https:\/\/doi.org\/10.1038\/s41419-023-05652-z","journal-title":"Cell Death Dis"},{"issue":"2","key":"251_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0022034515613507","volume":"95","author":"SG Shiah","year":"2015","unstructured":"Shiah SG, Shieh YS, Chang JY, 2015. The role of Wnt signaling in squamous cell carcinoma. J Dent Res, 95(2):129\u2013134. https:\/\/doi.org\/10.1177\/0022034515613507","journal-title":"J Dent Res"},{"issue":"6","key":"251_CR70","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/pharmaceutics15061653","volume":"15","author":"JPN Silva","year":"2023","unstructured":"Silva JPN, Pinto B, Monteiro L, et al., 2023. Combination therapy as a promising way to fight oral cancer. Pharmaceutics, 15(6):1653. https:\/\/doi.org\/10.3390\/pharmaceutics15061653","journal-title":"Pharmaceutics"},{"issue":"2","key":"251_CR71","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/odi.13967","volume":"29","author":"FM Silveira","year":"2023","unstructured":"Silveira FM, Schmidt TR, Neumann B, et al., 2023. Impact of photobiomodulation in a patient-derived xenograft model of oral squamous cell carcinoma. Oral Dis, 29(2):547\u2013556. https:\/\/doi.org\/10.1111\/odi.13967","journal-title":"Oral Dis"},{"key":"251_CR72","doi-asserted-by":"publisher","first-page":"712546","DOI":"10.3389\/fmolb.2021.712546","volume":"8","author":"AJ Smith","year":"2021","unstructured":"Smith AJ, Sompel KM, Elango A, et al., 2021. Non-coding RNA and frizzled receptors in cancer. Front Mol Biosci, 8:712546. https:\/\/doi.org\/10.3389\/fmolb.2021.712546","journal-title":"Front Mol Biosci"},{"key":"251_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12672-021-00429-2","volume":"12","author":"K Sompel","year":"2021","unstructured":"Sompel K, Elango A, Smith AJ, et al., 2021. Cancer chemoprevention through Frizzled receptors and EMT. Discov Oncol, 12:32. https:\/\/doi.org\/10.1007\/s12672-021-00429-2","journal-title":"Discov Oncol"},{"issue":"8","key":"251_CR74","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.molonc.2015.05.005","volume":"9","author":"G Srivastava","year":"2015","unstructured":"Srivastava G, Matta A, Fu GD, et al., 2015. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: implications for oral cancer therapy. Mol Oncol, 9(8):1720\u20131735. https:\/\/doi.org\/10.1016\/j.molonc.2015.05.005","journal-title":"Mol Oncol"},{"key":"251_CR75","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41421-023-00532-4","volume":"9","author":"LL Sun","year":"2023","unstructured":"Sun LL, Kang XD, Wang C, et al., 2023. Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinoma. Cell Discov, 9:28. https:\/\/doi.org\/10.1038\/s41421-023-00532-4","journal-title":"Cell Discov"},{"issue":"20","key":"251_CR76","doi-asserted-by":"publisher","first-page":"7714","DOI":"10.3390\/ijms21207714","volume":"21","author":"K Takabatake","year":"2020","unstructured":"Takabatake K, Kawai H, Omori H, et al., 2020. Impact of the stroma on the biological characteristics of the parenchyma in oral squamous cell carcinoma. Int J Mol Sci, 21(20):7714. https:\/\/doi.org\/10.3390\/ijms21207714","journal-title":"Int J Mol Sci"},{"issue":"1","key":"251_CR77","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ijo.2013.2172","volume":"44","author":"A Takeshita","year":"2014","unstructured":"Takeshita A, Iwai S, Morita Y, et al., 2014. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA. Int J Oncol, 44(1):59\u201368. https:\/\/doi.org\/10.3892\/ijo.2013.2172","journal-title":"Int J Oncol"},{"key":"251_CR78","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"YH Tan","year":"2023","unstructured":"Tan YH, Wang ZH, Xu MT, et al., 2023. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci, 15:44. https:\/\/doi.org\/10.1038\/s41368-023-00249-w","journal-title":"Int J Oral Sci"},{"issue":"35","key":"251_CR79","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/s41388-023-02783-7","volume":"42","author":"J Tasoulas","year":"2023","unstructured":"Tasoulas J, Srivastava S, Xu XN, et al., 2023. Genetically engineered mouse models of head and neck cancers. Oncogene, 42(35):2593\u20132609. https:\/\/doi.org\/10.1038\/s41388-023-02783-7","journal-title":"Oncogene"},{"issue":"10","key":"251_CR80","first-page":"4926","volume":"11","author":"JG Tian","year":"2018","unstructured":"Tian JG, Cui XG, Feng YD, et al., 2018. Inhibition of WNT7A-\u03b2-catenin signaling pathway sensitizes oral squamous cell carcinoma to cisplatin. Int J Clin Exp Pathol, 11(10):4926\u20134933.","journal-title":"Int J Clin Exp Pathol"},{"key":"251_CR81","doi-asserted-by":"publisher","first-page":"1096134","DOI":"10.3389\/fonc.2022.1096134","volume":"12","author":"SA Umar","year":"2022","unstructured":"Umar SA, Dong B, Nihal M, et al., 2022. Frizzled receptors in melanomagenesis: from molecular interactions to target identification. Front Oncol, 12:1096134. https:\/\/doi.org\/10.3389\/fonc.2022.1096134","journal-title":"Front Oncol"},{"issue":"15","key":"251_CR82","doi-asserted-by":"publisher","first-page":"12046","DOI":"10.3390\/ijms241512046","volume":"24","author":"O Urz\u00ec","year":"2023","unstructured":"Urz\u00ec O, Gasparro R, Costanzo E, et al., 2023. Three-dimensional cell cultures: the bridge between in vitro and in vivo models. Int J Mol Sci, 24(15):12046. https:\/\/doi.org\/10.3390\/ijms241512046","journal-title":"Int J Mol Sci"},{"issue":"2","key":"251_CR83","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2011.11.027","volume":"317","author":"AK Vahle","year":"2012","unstructured":"Vahle AK, Kerem A, \u00d6zt\u00fcrk E, et al., 2012. Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice \u2013 role of toll-like-receptor 4 expressed on host cells. Cancer Lett, 317(2):199\u2013206. https:\/\/doi.org\/10.1016\/j.canlet.2011.11.027","journal-title":"Cancer Lett"},{"issue":"5","key":"251_CR84","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ijrobp.2023.09.044","volume":"118","author":"P Verrelle","year":"2024","unstructured":"Verrelle P, Gestraud P, Poyer F, et al., 2024. Integrated high-throughput screening and large-scale isobolographic analysis to accelerate the discovery of radiosensitizers with greater selectivity for cancer cells. Int J Radiat Oncol Biol Phys, 118(5):1294\u20131307. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"251_CR85","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s12105-019-01114-1","volume":"14","author":"G Vijayakumar","year":"2020","unstructured":"Vijayakumar G, Narwal A, Kamboj M, et al., 2020. Association of SOX2, OCT4 and WNT5A expression in oral epithelial dysplasia and oral squamous cell carcinoma: an immunohistochemical study. Head Neck Pathol, 14(3):749\u2013757. https:\/\/doi.org\/10.1007\/s12105-019-01114-1","journal-title":"Head Neck Pathol"},{"key":"251_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0065-230X(10)06004-5","volume":"106","author":"JC Walrath","year":"2010","unstructured":"Walrath JC, Hawes JJ, van Dyke T, et al., 2010. Genetically engineered mouse models in cancer research. Adv Cancer Res, 106:113\u2013164. https:\/\/doi.org\/10.1016\/s0065-230x(10)06004-5","journal-title":"Adv Cancer Res"},{"issue":"1","key":"251_CR87","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1515\/biol-2021-0104","volume":"16","author":"YF Wang","year":"2021","unstructured":"Wang YF, Cao Z, Liu FJ, et al., 2021. Clinical significance of activated Wnt\/\u03b2-catenin signaling in apoptosis inhibition of oral cancer. Open Life Sci, 16(1):1045\u20131052. https:\/\/doi.org\/10.1515\/biol-2021-0104","journal-title":"Open Life Sci"},{"key":"251_CR88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/tpj.2017.28","volume":"18","author":"ZM Wang","year":"2018","unstructured":"Wang ZM, Luo JQ, Xu LY, et al., 2018. Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases. Pharmacogenomics J, 18(3):351\u2013358. https:\/\/doi.org\/10.1038\/tpj.2017.28","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"251_CR89","doi-asserted-by":"publisher","first-page":"103426","DOI":"10.1016\/j.drudis.2022.103426","volume":"28","author":"J Wanigasekara","year":"2023","unstructured":"Wanigasekara J, Cullen PJ, Bourke P, et al., 2023. Advances in 3D culture systems for therapeutic discovery and development in brain cancer. Drug Discov Today, 28(2):103426. https:\/\/doi.org\/10.1016\/j.drudis.2022.103426","journal-title":"Drug Discov Today"},{"key":"251_CR90","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fphar.2020.00098","volume":"11","author":"H Xie","year":"2020","unstructured":"Xie H, Ma YD, Li J, et al., 2020. WNT7A promotes EGF-induced migration of oral squamous cell carcinoma cells by activating \u03b2-catenin\/MMP9-mediated signaling. Front Pharmacol, 11:98. https:\/\/doi.org\/10.3389\/fphar.2020.00098","journal-title":"Front Pharmacol"},{"key":"251_CR91","doi-asserted-by":"publisher","first-page":"590912","DOI":"10.3389\/fmolb.2020.590912","volume":"7","author":"J Xie","year":"2021","unstructured":"Xie J, Huang L, Lu YG, et al., 2021. Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma. Front Mol Biosci, 7:590912. https:\/\/doi.org\/10.3389\/fmolb.2020.590912","journal-title":"Front Mol Biosci"},{"key":"251_CR92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40644-023-00552-z","volume":"23","author":"F Xu","year":"2023","unstructured":"Xu F, Peng LL, Feng JY, et al., 2023. A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables. Cancer Imaging, 23:34. https:\/\/doi.org\/10.1186\/s40644-023-00552-z","journal-title":"Cancer Imaging"},{"issue":"2","key":"251_CR93","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3724\/abbs.2022132","volume":"55","author":"WB Yang","year":"2023","unstructured":"Yang WB, Zhang SH, Li TL, et al., 2023. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-\u03b2\/Smad pathway. Acta Biochim Biophys Sin (Shanghai), 55(2):262\u2013273. https:\/\/cstr.cn\/32197.14.abbs.2022132","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"251_CR94","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"FY Yu","year":"2021","unstructured":"Yu FY, Yu CH, Li FF, et al., 2021. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther, 6:307. https:\/\/doi.org\/10.1038\/s41392-021-00701-5","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"251_CR95","doi-asserted-by":"publisher","first-page":"e3035","DOI":"10.1038\/cddis.2017.433","volume":"8","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Xie XY, Jiang YC, et al., 2017. LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS. Cell Death Dis, 8(9):e3035. https:\/\/doi.org\/10.1038\/cddis.2017.433","journal-title":"Cell Death Dis"},{"issue":"11","key":"251_CR96","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41571-022-00682-6","volume":"19","author":"ER Zanella","year":"2022","unstructured":"Zanella ER, Grassi E, Trusolino L, 2022. Towards precision oncology with patient-derived xenografts. Nat Rev Clin Oncol, 19(11):719\u2013732. https:\/\/doi.org\/10.1038\/s41571-022-00682-6","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"251_CR97","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ijms19051543","volume":"19","author":"CM Zeng","year":"2018","unstructured":"Zeng CM, Chen Z, Fu L, 2018. Frizzled receptors as potential therapeutic targets in human cancers. Int J Mol Sci, 19(5):1543. https:\/\/doi.org\/10.3390\/ijms19051543","journal-title":"Int J Mol Sci"},{"issue":"2","key":"251_CR98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jphs.2019.03.005","volume":"140","author":"CP Zhang","year":"2019","unstructured":"Zhang CP, Hao YL, Sun YY, et al., 2019. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22\/WNT1\/\u03b2-catenin axis. J Pharmacol Sci, 140(2):128\u2013136. https:\/\/doi.org\/10.1016\/j.jphs.2019.03.005","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"251_CR99","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3892\/or.2015.4285","volume":"34","author":"EJ Zhang","year":"2015","unstructured":"Zhang EJ, Li ZN, Xu ZF, et al., 2015. Frizzled2 mediates the migration and invasion of human oral squamous cell carcinoma cells through the regulation of the signal transducer and activator of transcription-3 signaling pathway. Oncol Rep, 34(6):3061\u20133067. https:\/\/doi.org\/10.3892\/or.2015.4285","journal-title":"Oncol Rep"},{"key":"251_CR100","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/s41598-017-02261-7","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu SH, Qu DW, et al., 2017. Kif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in cross-talking with OSCC. Sci Rep, 7:2226. https:\/\/doi.org\/10.1038\/s41598-017-02261-7","journal-title":"Sci Rep"},{"key":"251_CR101","doi-asserted-by":"publisher","first-page":"750031","DOI":"10.3389\/fphar.2021.750031","volume":"12","author":"YH Zhang","year":"2021","unstructured":"Zhang YH, Zhang YS, Niu WW, et al., 2021. Experimental study of almonertinib crossing the blood-brain barrier in EGFR-mutant NSCLC brain metastasis and spinal cord metastasis models. Front Pharmacol, 12:750031. https:\/\/doi.org\/10.3389\/fphar.2021.750031","journal-title":"Front Pharmacol"},{"issue":"2","key":"251_CR102","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.21037\/tcr.2019.12.50","volume":"9","author":"YL Zhang","year":"2020","unstructured":"Zhang YL, Zu D, Chen Z, et al., 2020. An update on Wnt signaling pathway in cancer. Transl Cancer Res, 9(2):1246\u20131252. https:\/\/doi.org\/10.21037\/tcr.2019.12.50","journal-title":"Transl Cancer Res"},{"issue":"33","key":"251_CR103","doi-asserted-by":"publisher","first-page":"22589","DOI":"10.1074\/jbc.M114.560979","volume":"289","author":"YQ Zhang","year":"2014","unstructured":"Zhang YQ, Liu CX, Duan XL, et al., 2014. CREPT\/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the \u03b2-catenin-TCF4 transcriptional activity in response to Wnt signaling. J Biol Chem, 289(33):22589\u201322599. https:\/\/doi.org\/10.1074\/jbc.M114.560979","journal-title":"J Biol Chem"},{"key":"251_CR104","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jconrel.2024.03.014","volume":"368","author":"BR Zhao","year":"2024","unstructured":"Zhao BR, Qin X, Fu R, et al., 2024. Supramolecular nanodrug targeting CDK4\/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma. J Control Release, 368:623\u2013636. https:\/\/doi.org\/10.1016\/j.jconrel.2024.03.014","journal-title":"J Control Release"},{"key":"251_CR105","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1186\/s12885-018-4806-7","volume":"18","author":"L Zhong","year":"2018","unstructured":"Zhong L, Liu YT, Wang K, et al., 2018. Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma. BMC Cancer, 18:911. https:\/\/doi.org\/10.1186\/s12885-018-4806-7","journal-title":"BMC Cancer"},{"issue":"2","key":"251_CR106","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2485\/jhtb.14.247","volume":"14","author":"EX Zhu","year":"2005","unstructured":"Zhu EX, Li XM, Zhu L, et al., 2005. Expression of Wnt5a and \u03b2-catenin in Chinese oral squamous cell carcinoma of tongue. J Hard Tissue Biol, 14(2):247\u2013248. https:\/\/doi.org\/10.2485\/jhtb.14.247","journal-title":"J Hard Tissue Biol"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2400251\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:03:48Z","timestamp":1763708628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2400251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":106,"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2400251","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Muhammad TUFAIL, Caiyun HE, Canhua JIANG, and Ning LI declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This review does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}